Latest Asx News

Enlitic, Inc. has launched a two-tranche institutional placement to raise A$10 million, underpinning its strategic collaboration with GE HealthCare and fueling expansion in AI-enabled medical imaging data migration.

Enlitic has formalised a binding MOU with GE HealthCare to deliver multi-million-dollar migration services, contingent on raising A$10 million through a new capital placement. This partnership and funding round mark a pivotal step in Enlitic’s growth strategy within AI-driven medical imaging.

AVJennings reported a 25% rise in Q3 FY25 contract signings and a 26% increase in settlements, while progressing an acquisition scheme that could reshape its future.

Waratah Minerals’ maiden drilling at Breccia West within the Spur Gold-Copper Project has intersected substantial porphyry copper-gold mineralisation, validating its exploration strategy and highlighting a compelling new drill target.

Apollo Minerals has completed its 2025 Phase 2 drilling at the Salanie Gold Project, revealing significant shallow high-grade gold mineralisation and confirming continuity across key prospects within a prolific greenstone belt.

US Masters Residential Property Group has amended its loan agreement with Global Atlantic, significantly lowering its Tangible Net Worth covenant to align with a strategic sales-driven reduction in debt.

Global uranium enrichment leader Urenco has agreed to invest A$5 million in Australian technology developer Ubaryon, forming a strategic partnership that validates and accelerates a novel uranium enrichment process.

AdAlta Limited has announced a pro rata renounceable rights offer to raise approximately $1.29 million, aiming to fund its strategic pivot towards licensing CAR-T cell therapies through its subsidiary AdCella. The offer includes new shares and options, underpinned by key insiders and an underwriting agreement.

Anagenics Ltd has reported a significant earnings turnaround in 3Q25 following a strategic business restructure, alongside securing a multi-year royalty agreement worth $4.4 million with York Street Brands.

Neurizon Therapeutics has announced the successful completion of its Open-Label Extension study for NUZ-001 in ALS, revealing significant survival benefits and strong tolerability. The company is on track to release top-line results in Q3 2025 and advance to a pivotal Phase 2/3 trial.

Caspin Resources has raised $2.1 million through a two-tranche equity placement to fund ongoing exploration at its promising Bygoo Tin Project, following encouraging high-grade drill results. The capital raise underscores strong investor confidence as further assay and metallurgical results are anticipated soon.

Eastern Metals has agreed to sell its 1.5% net smelter royalty on the Thomson Project to Red Hill Minerals for $220,000 cash, marking a strategic monetisation of its residual interest in the asset.